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Abstract
Computed tomography (CT) has great clinical utility and its usage has 
increased dramatically over the years. Concerns have been raised, however, 
about health impacts of ionising radiation exposure from CTs, particularly in 
children, who have a higher risk for some radiation induced diseases. Direct 
estimation of the health impact of these exposures is needed, but the conduct 
of epidemiological studies of paediatric CT populations poses a number of 
challenges which, if not addressed, could invalidate the results.
The aim of the present paper is to review the main challenges of a study 
on the health impact of paediatric CTs and how the protocol of the European 
collaborative study EPI-CT, coordinated by the International Agency for 
Research on Cancer (IARC), is designed to address them.
The study, based on a common protocol, is being conducted in Belgium, 
Denmark, France, Germany, the Netherlands, Norway, Spain, Sweden and 
the United Kingdom and it has recruited over one million patients suitable 
for long-term prospective follow-up. Cohort accrual relies on records of 
participating hospital radiology departments. Basic demographic information 
and technical data on the CT procedure needed to estimate organ doses are 
being abstracted and passive follow-up is being conducted by linkage to 
population-based cancer and mortality registries. The main issues which 
may affect the validity of study results include missing doses from other 
radiological procedures, missing CTs, confounding by CT indication and 
socioeconomic status and dose reconstruction. Sub-studies are underway to 
evaluate their potential impact.
By focusing on the issues which challenge the validity of risk estimates 
from CT exposures, EPI-CT will be able to address limitations of previous 
CT studies, thus providing reliable estimates of risk of solid tumours 
and leukaemia from paediatric CT exposures and scientific bases for the 
optimisation of paediatric CT protocols and patient protection.
Keywords: CT scan, cohort study, epidemiological methods, cancer, 
leukaemia
S  Online supplementary data available from stacks.iop.org/JRP/35/030611/
mmedia
(Some figures may appear in colour only in the online journal)
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1. Introduction
Computed tomography (CT) scanning is an essential imaging technique for diagnosis and 
follow-up of certain conditions, and its use has grown in all age groups since its introduction 
in the 1970s [1]. Concerns have been raised about cancer risks related to ionising radiation 
exposure from CTs, particularly in children, whose longer expected lifespan translates into a 
higher number of years at risk of developing a radiation-induced malignancy. Further, chil-
dren, due to their smaller body mass, tend to receive higher organ doses than adults if the same 
CT protocol is not size adapted [2] or if the clinical practice at the hospital does not apply age 
and weight-based scanning guidelines [3]. It is also well known that exposure in childhood 
leads to higher risk of cancer, than similar exposure in adults [4].
Though radiation doses to specific organs from a CT scan are typically low (1–10 mGy), 
a small proportion of patients with repeated CT scans receives moderate doses, in the range 
100–150 mGy [5] at which increased cancer risks have been demonstrated in epidemiologi-
cal studies [6, 7]. Given the large number of children undergoing CTs in developed coun-
tries, the public health and radiation protection implications of this exposure are potentially 
important.
The most comprehensive quantitative estimates of cancer risk following low linear energy 
transfer (LET) radiation exposure come from studies of the atomic bomb (A-bomb) survivors 
[8]. This large cohort study concluded that radiation-related risk for all cancers—and particu-
larly for leukaemia, breast, brain and thyroid cancer—is greatest for exposure in childhood 
and adolescence [9, 10]. Risk estimates, primarily based on this study, have been used to pre-
dict the potential health impact of CT scanning on cancer risk [11–13]. Although the A-bomb 
survivors study featured a large well-characterised all-ages cohort with a long large-scale 
follow-up for the study of health effects associated with ionising radiation, some important 
uncertainties remain unsolved, including: the shape of the dose-response model for doses 
lower than 100 mSv, particularly when received at low dose-rates in a protracted or fraction-
ated fashion and whether the risks identified from a Japanese population can be applied to 
any other ethnicity with different baseline cancer risks [5, 10, 14]. Increasingly, studies of 
occupational exposures [15, 16] and of environmental exposures [17–19]—including studies 
of natural background radiation [20, 21]—are providing important complementary informa-
tion on effects of low dose protracted exposure in Western populations. However, with the 
exception of those based on environmental exposure, these studies do not provide information 
about risks from childhood exposure. Careful studies of large populations with paediatric CT 
exposure are therefore needed to directly estimate the health effects of these exposures.
Several epidemiological studies on cancer risk related to CT-scanning in young peo-
ple have recently been published [22–26]. Two of them (Pearce [22] and Mathews [23]) 
found increased risks for leukaemia and brain tumours associated with CT scan exposure. 
A third study by Huang and co-authors did not evaluate leukaemia risks but also found an 
increased risk of benign brain tumours associated with paediatric head CT examinations [24]. 
Despite the apparent consistency of results, these papers have received criticism for several 
reasons. In the Pearce study, based on a cohort of over 175 000 exposed young people in the 
M Bosch de Basea et alJ. Radiol. Prot. 35 (2015) 611
614
UK [22], there were concerns over potential organ-dose errors, and the possible inclusion 
of patients with cancer predisposing syndromes (such as Down syndrome or neurofibroma-
tosis type1, among others) and, benign conditions with malignant transformation potential. 
The Mathews study [23], comparing cancer incidence between 680 000 exposed and over 10 
million unexposed Australians, used very limited dosimetric methods. The study imputed an 
average effective dose as well as bone marrow and brain doses for each type of CT from the 
published literature, scaled to the paediatric population. This could have potentially led to 
substantial exposure misclassification as exposures from CTs are not uniform over the whole 
body. The study also reported an unusual finding of increased risk for a large number of very 
different malignancies. Again, information on patients with tumour and leukaemia predispos-
ing syndromes was not available, and therefore, were not excluded. As for Huang et al [24] 
they compared cancer risk between a group of over 24 000 persons with at least one brain CT 
and a group of 24 418 randomly selected unexposed people. The main limitations of this study 
were the short follow-up of the participants, the absence of any dosimetric reconstruction 
impeding the study of dose-response relationships and the short exclusion period of incident 
cases after the first exposure which may have allowed for some confounding by indication 
(lag period of 2 years).
The EPI-CT multinational collaborative study, which aims to estimate individual radiation 
organ doses and associated uncertainties from CTs in young people and to assess subsequent 
cancer risk, was specifically designed to address factors which can affect the interpretation of 
results from CT studies, including reverse causation, confounding by predisposing factors and 
other causes as well as possible effect modification through a number of sub-studies. These 
– and the results of the first of these sub-studies—will be described below.
EPI-CT builds upon some pre-existing cohort studies in France [27], the UK [22] and 
Germany [28], extending them and setting-up new cohorts based on a common protocol, in 
Belgium, Denmark, the Netherlands [29], Norway, Spain and Sweden. The current paper 
describes the design of the study, its methodological challenges and approaches implemented 
to address these.
Separate publications present the dose reconstruction approach developed within the pro-
ject [30] and results of sub-studies on biomarkers of DNA damage, oxidative stress and gene 
expression profiling after CT exposure [31]. Additional papers will present recommenda-
tions for patient dose optimisation, based on analyses of international data collected within 
EPI-CT.
2. Methods
EPI-CT is a European multinational cohort study of patients who have undergone at least 
one CT scan before the age of 21 years, and for some countries 0–21 inclusive. The main 
objectives are the establishment of a large-scale multinational cohort of paediatric patients for 
long-term follow-up (subject to funding being secured); the description of patterns of use of 
paediatric and young adult CT over time and among countries; the improvement of individual 
organ-dose estimates from paediatric and young adult CTs and the evaluation of the radiation-
related risk of diseases—particularly leukaemia and brain cancer (neoplasms related to radia-
tion and the most common childhood malignancies) and non-cancer diseases (cardiovascular 
diseases, among others). The assessment of biological markers of CT-irradiation effects and 
dose optimisation in paediatric radiology in Europe are also important aims of the study.
As required in each country, ethical and other approvals must be gained, prior to commenc-
ing any epidemiological study.
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Within EPI-CT, although the study methodology and its ethical implications are identical 
for all national cohorts, different guidelines apply in different countries to safeguard the rights 
and privacy of the patients in the study (table 3). These differences range from gaining a sin-
gle approval from a national authority to obtaining individual ethical approval in each of the 
enrolled hospitals, which greatly delayed and hindered the study setting up in some countries.
2.1. Study methodology and challenges
2.1.1. The study population
Though CT scans can be performed in a large number of radiological facilities, including in 
some countries, private radiological clinics, it is not logistically feasible to include patients 
from all hospitals and clinics with a radiology department in a given region or country. The 
study population is therefore defined on the basis of the large paediatric hospitals and of 
the radiology service of hospitals with a large paediatric patient population in participating 
countries.
The cohort is defined retrospectively (and in some countries prospectively) from the 
records of participating hospital radiology departments. Eligible subjects should have at least 
one recorded CT scan before the age of 22 years and be cancer-free at the time of the first CT. 
Due to logistical aspects of follow-up (e.g. countries with only paediatric cancer registries) 
or cohort identification (patterns of referral of adolescent and young adults) the age range is 
narrower in some countries (table 1).
Only residents of the participating countries/regions are eligible for inclusion in the study 
population to ensure the feasibility of follow-up.
2.1.2. Sample size and statistical power
The risk of radiation-induced cancer following exposure to low doses is estimated to be 
small [1] and it is typically considered that a whole body dose of 1 Sv (which is 100 times 
higher than the dose in the CT scan examination involving the highest radiation exposure: 
an abdomen/pelvis CT scan) leads to an approximately 5% increase in the risk of fatal can-
cers. For children and teenagers, this risk may be 2 or 3 times higher [32]. Given the likely 
small carcinogenic effects, large collaborative studies are required to achieve adequate 
statistical power to significantly identify a potential radiation-induced increase of cancer 
cases [33], particularly for rare diseases such as childhood cancers (annual incidence rate 
about 145 per 100 000 aged 0–19 years in Europe [34]). Adequate power calculations are 
therefore needed prior to setting up a study to ensure that the study size is sufficient to be 
informative about such risks.
Table 1 describes the planned national cohorts in EPI-CT, which based on a priori 
study power calculations (included in the additional material section) (stacks.iop.org/
JRP/35/030611/mmedia) should ensure sufficient statistical power to evaluate the asso-
ciation between radiation dose from CT scans and risk of leukaemia and possibly of 
brain tumour within the time-frame of the current EU grant agreement (2011–2017).
Based on the data collected to date, it is foreseen that the international pooled EPI-CT 
cohort will include approximately 1200 000 patients, exceeding the approximately 1000 000 
patients initially planned.
2.1.3. Follow-up
Within EPI-CT, cohort members are being followed-up passively through linkage to can-
cer, mortality and other national/regional registries (including centralised hospital discharge 
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databases), to determine incidence and mortality from leukaemia, cancer and non-cancer 
causes in the cohort. Follow-up starts at the date of the first CT in a participating radiology 
service and ends at the earliest of data of death, incidence of a disease of interest (here leu-
kaemia and solid cancers, in particular brain tumours), emigration (where available) or end of 
follow-up in the participating country/region. The population is being followed-up into adult-
hood in all countries except France and Germany where currently national cancer registries 
only include cancer diagnoses up to the age of 15.
Within the framework of the current EC grant, the cohort is still relatively young and the 
power to study the relation between radiation dose in young people and risk of diseases, such 
as cardiovascular diseases and many solid cancers which are more frequent at older ages, will 
be inadequate. Further follow-up will be needed for this.
2.1.3.1. Challenges. As in all cohort studies, emigration information is not comprehensively 
available in most countries. The exceptions for EPI-CT are Denmark, Norway, Sweden and 
part of the UK. Emigration, when not known, may challenge the adequacy of risk estimates 
in the study: incident cases will be lost, while person-years at risk will be overestimated, thus 
leading to bias in the risk estimates. A sub-study in the countries where emigration data are 
available will provide information on the magnitude and direction of the possible bias related 
to lack of emigration data. Simulation studies will be conducted based on this information 
and on other credible scenarios of missing data in order to evaluate the impact of missing 
 emigration data on the magnitude of the risk estimates.
Mortality follow-up is feasible in all countries except Germany and, in part, France. In 
these countries, subjects who have died will not be identified and will continue to contribute 
person-years at risk in the analyses, leading to overestimation of person-years and biased risk 
Table 1. National contribution to the EPI-CT cohort, as initially planned.
Country Study population
Age 
(years)
Planned 
period 
of cohort 
accrual
Targeted 
cohort 
size (N)
Targeted 
contribution to 
the European 
EPI-CT cohort
Current 
cohort 
size (N)
Belgium Patients from 
participating hospitals
0–18 2001– 2013 30 000 2.9% 14 500
Denmark Patients from 
participating hospitals
0–18 2001–2013 30 000 2.9% 10 000
France Patients from 
participating hospitals
0–10 2000–2013 90 000 8.7% 130 000
Germany Patients from 
participating hospitals
0–15 1980–2013 140 000 13.6% 51 000
Netherlands Patients from 
participating hospitals
0–18 1983–2013 40 000 3.9% 150 000
Norway Patients from 
participating hospitals
0–20 1980–2013 20 000 1.9% 87 000
Spain Patients from 
participating hospitals
0–20 1991–2013 200 000 19.4% 177 000
Sweden Patients from 
participating hospitals
0–18 1984–2013 95 000 9.2% 96 000
UK Patients from 
participating hospitals
0–21 1985–2013 387 000 37.5% 405 000
Total accrued patients 1980–2013 1032 000 100.0% 1120 500
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estimates. While this is generally not a major issue in studies of young people where mortality 
rates are low, it is of concern in a study of CT patients, who tend to have a substantially higher 
mortality risk than the general population (due to the inclusion of patients with severe and 
often life-shortening diseases). Analyses using data from the other study countries will allow 
the evaluation of the magnitude and direction of the possible bias related to lack of mortality 
data in Germany and France. Simulation studies will be conducted based on this information 
and on other credible scenarios of missing data in order to evaluate the impact of missing 
mortality data on the magnitude of the risk estimates.
2.1.4. Dosimetric data collection
Proper exposure assessment is critical in any epidemiological study and especially challeng-
ing in studies in which direct measurement of exposure is not possible, due to the retrospective 
nature of the data collection or to elevated costs.
In EPI-CT, computerised data are being collected for every scan a cohort member under-
went in any of the participating hospitals of his/her country. This includes basic radiological 
data from the Radiological Information Systems—RIS—including date of scan, body region 
scanned, sex and date of birth. In addition, for recent periods, data are being collected from 
the Picture Archiving and Communication System—PACS—which contains much more 
detail about the examination including the technical parameters used for each specific scan. 
This is being achieved using dedicated software, such as PerMoS (Luxembourg Institute 
of Science and Technology, Luxembourg) [28, 35] or Gladys (Qaelum NV, Belgium) [36], 
which extract information from the DICOM (Digital Imaging and Communications in 
Medicine header) header of the scan from the computer servers of participating radiological 
departments.
2.1.4.1. Challenges. Epidemiological studies on diagnostic ionising radiation exposure 
 ideally demand a complete reconstruction of the radiological history of the patient. Risk 
estimates may be impacted by the fact that CT data are only being collected from partici-
pating hospitals, as was the case in the UK [22] and Australian [23] studies as well as in 
the countries participating in EPI-CT, or only collected on specific procedures (as in the 
Taiwanese study [24]). Estimated doses, therefore, will not include doses from scans per-
formed in other non-participating hospitals or doses received from other irradiating medical 
procedures. If there is a relation between the number of scans in participating hospitals 
and doses from CTs conducted elsewhere and/or from other procedures, this will induce 
confounding.
EPI-CT is assessing the potential impact on risk estimates of unaccounted exposure 
sources through a number of sub-studies conducted in regions where all hospitals and/or 
all ionising radiation medical procedures are included. The most common ionising radia-
tion procedure besides CT scanning is conventional radiography, which entails very low 
radiation doses compared to CT (typical organ doses in the range 0.005–0.15 mGy depend-
ing on body part examined [37, 38], compared to several mGy from CTs for organs in the 
field) and will, therefore, have little impact on risk estimates. Regarding missing doses from 
unaccounted CT scans, results are already available from the UK, indicating that only a 
small number of patients (2.3%) in the study age-range received scans in other hospitals, 
and hence the impact of such missing doses may be small [39]. In Belgium, information on 
CTs and other radiological examinations was obtained from the health insurance system for 
a 2.5% sample of the Belgian population. The proportion of children who had numerous 
imaging tests (mostly conventional radiography) was significantly higher for those who had 
had a CT compared to those who had not had a CT scan. In France, in a sub-study based on 
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health insurance data it was observed that around 80% of the annual dose received by chil-
dren who already had a CT scan is due to other CT scans and therefore, additional ionising 
radiation doses from other radiological procedures accounted only for a small part of their 
total dose [40].
Population and/or hospital-based registries of radiological procedures in other countries 
will also provide information on missing examinations. With this information, credible sce-
narios will be identified and simulation studies conducted to assess the influence of missing 
doses on risk estimates and to correct, if possible, for a potential confounding bias.
2.1.5. Dose reconstruction
In studies of low-dose ionising radiation, the direct estimation of the health impact of radiation 
remains imprecise, and an accurate dosimetry and assessment of potential biases and uncer-
tainties is needed. This is crucial to ensure the validity of the resulting risk estimates.
EPI-CT plans to improve the organ dose estimation methodology currently used in similar 
studies by combining the results of national surveys on doses from CT examinations [22]; 
standard examination protocols from different hospitals in different time periods and the real 
settings used for CT imaging recorded once PACS was implemented at the hospitals [30]. 
The standard examination protocols will provide information about typical machine settings 
that influence the delivered dose used in paediatric and young adult CT examinations when 
individual settings for each examination were not available (period where hospitals were man-
aging their radiological information using RIS only, typically before the year 2000). Missing 
settings will be imputed through simulations, providing multiple alternative dose estimates for 
each subject and each scan accounting for shared errors in dosimetric model parameters [41]. 
Multiple realisations of the cumulative individual doses to specific relevant organs (e.g. red 
bone marrow for analyses of leukaemia risk) will be generated for all examinations included 
in the study and appropriate statistical methods (including Monte Carlo Maximum Likelihood 
[42, 43] and Bayesian averaging approaches) will be implemented to assess the risk of radia-
tion induced disease in these organs taking into account the uncertainty in the dosimetric 
model. The methodology for dose-estimation from RIS and PACS data has been published 
elsewhere [30].
2.2. Potential sources of bias
Incorrect assessment of the association between an exposure and an effect in the studied popu-
lation will invalidate results. Thus it is important to identify and characterise potential sources 
of bias in order to minimise them and/or take them into account in statistical analyses, as 
appropriate.
In EPI-CT, a priori potential bias factors of the association between ionising radiation 
exposure from CT scans and risk of leukaemia and solid tumours include socioeconomic 
status (SES), confounding by indication (i.e. the reason for the CT being a precursor or risk 
factor for the cancer, such as congenital disorders entailing a higher cancer risk) and reverse 
causation.
2.2.1. Socioeconomic status
The influence of socioeconomic status—often employed as a surrogate for unmeasured life-
style factors—in the variation of disease burden rates is widely accepted by the scientific 
community. At the same time, SES can be related to exposure to certain environmental factors, 
thus potentially confounding any observed association between exposure and health outcome.
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As SES indicators are not available in some EPI-CT countries, the potential impact of 
missing socioeconomic status is being assessed through sub-studies in those regions where 
SES data are available.
Within EPI-CT, different indicators of SES have been used in the different countries, based, 
as available, on parents’ job title or education level from census data, or through geocoding 
the subjects’ address from radiological records and linking with maps of geographical distri-
bution of SES (table 2). Preliminary results are available from sub-studies that have been run 
in the UK, the Netherlands, Belgium and Spain, based on heterogeneous SES indicators. UK 
data [44] suggest that young people from deprived areas are more likely to undergo CT scans 
than those in more affluent areas, possibly reflecting injury rate disparities and highlighting 
the potential confounding effect of SES. Similarly, in Belgium, young patients belonging to 
the less affluent socioeconomic group had more CT scans per patient on average than those 
in the more affluent group (1.4 versus 1.2 CT scans per patient, respectively) (unpublished 
data). Results of the Dutch sub-study indicated that children from deprived SES categories, 
whether based on income or house value, are slightly overrepresented among children with at 
least one CT scan based on a sample from a large academic hospital in a poor urban area of 
Amsterdam, compared with a random sample from the Dutch population. Little change, how-
ever, was observed in the SES categories by number of scans [29]. Results based on 3 different 
autonomous communities in Spain, on the other hand, show decreasing number of CT scans 
associated with a lower SES level based on residence area (unpublished data). Disparities 
in these results may reflect differences in the healthcare systems between the countries as 
well as differences in the adequacy of the measure of SES. To better understand the possible 
confounding effect of SES and its likely magnitude where data are unavailable, a sub-study 
is underway comparing different SES indicators (in countries where they are available) and 
evaluating whether the results differ depending on the size of the geographic area on which 
SES is determined (which vary between countries from a few 10s of inhabitants to several 
thousands). Results will also be compared, where possible, for different age groups, scan 
types and, where available, reasons for scans.
2.2.2. Confounding by indication due to cancer predisposing factors
A number of syndromes or diseases are known to be associated with an increased risk of 
some tumours, including individuals with inactivation of tumour suppressor genes, altera-
tions in DNA repair genes, or non-malignant chronic immune deficiency syndromes [45, 46]. 
If patients with such syndromes or diseases are also at higher risk of undergoing CT, there is 
the potential that these predisposing factors may bias the association between radiation dose 
from CT scans and risk of cancer, a criticism raised about the studies by Pearce, Matthews 
and Huang.
Within the EPI-CT study, where possible, centres are using available sources (including 
detailed reviews of clinical information, pathology reviews, and registries of congenital mal-
formations, rare diseases and bone marrow transplants) to attempt to identify these patients, 
evaluate whether they confound the association and, if so, to adjust for them in the statistical 
analyses.
In a recent publication Journy and co-authors published results concerning the follow-up 
of part of the French component of the EPI-CT study, including a very thorough review of the 
presence of cancer predisposing factors [25]. The study included 67 000 children with a CT 
scan. Among these 1.7% of the children had predisposing conditions to leukaemia, and 0.5% 
to Central Nervous System (CNS) tumours (this proportion is quite high, probably due, as the 
authors indicate, to the participation of a major paediatric referral centre). Despite these small 
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Table 2. Estimators and sources of information to assess the SES confounding and 
confounding by indication effect.
Country
Socioeconomic status Cancer cases and other high risk factors for cancer
SES 
estimator 
(at the time 
of the last 
CT scan)
Source of 
information
Variables for 
identification of 
cancer cases and 
other high risk 
factors for cancer
Information 
recorded Source of information
Belgium Geographic 
estimate 
(residence 
postal code)
National 
census data
(1) Cancer 
diagnosis;
(1) Cancer 
diagnosis;
(1)National Cancer 
Registry; (2)Sub-
study of 680 children 
with CT followed for 
6 months based on 
medical records
(2) Descriptive 
statistics for a 
subsample
(2) 
Indication 
and results 
(findings/
diagnosis) 
of the scans
Denmark Parental 
education
National 
education 
registry
Cancer diagnoses, 
other relevant 
diagnosis 
identified in 
National registries
Diagnoses, 
ICD-format, 
free text
National Cancer 
Registry, National 
Hospital Discharge 
Registry
France Geographic 
estimate 
(residence 
postal code)
National 
census data
Medical 
diagnoses 
associated with 
hospitalisation, 
cancer diagnosis
Cancer / non 
cancer
Medical identifying 
records/ paediatric 
cancer registry
Germany Geographic 
estimate 
(residence 
postal code)
National 
census data
Indication, results 
and clinical 
information
Risk group Medical records
The 
Netherlands
Geographic 
estimate 
(residence 
postal code)
National 
census data
Cancer diagnoses, 
birth defects (e.g. 
Down syndrome), 
CT indication, 
leukaemogenic 
drugs
Diagnoses, 
ICD-format, 
free text
Netherlands Cancer 
Registry, Perinatal 
Registry of the 
Netherlands, Bone 
Marrow Transplant 
registry
Norway Parental 
education
National 
education 
registry
Cancer diagnoses, 
Down syndrome, 
birth defects
Diagnoses, 
ICD-format
Cancer Registry of 
Norway, Medical Birth 
Registry
Spain Geographic 
estimate 
(residence 
postal code)
Synthetic 
index of urban 
vulnerabilitya
Cancer diagnoses Diagnoses, 
ICD-format
Medical Hospital 
Discharge Registry 
records
Sweden Parental 
education
National 
census data
Cancer diagnoses, 
Down syndrome
Diagnoses, 
ICD-format
Cancer Registry of 
Sweden, National 
Inhospital Registry
UK Geographic 
estimate 
(residence 
postal code)
National 
census data
Cancer diagnoses Diagnoses, 
ICD-format
National Health 
Service Central 
Registry
a Index based on % of unemployed population, % of young unemployed population, % of temporary unemployed 
population, % of non-skilled employed population and % illiterate population per census-tract section.
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numbers, children with predisposing conditions accounted respectively for 32% and 26% of 
the incident cases of leukaemia and CNS tumours. Though the number of cases in the entire 
cohort was low (27 CNS tumours, 25 leukaemia and 21 lymphoma), and the follow-up was 
quite short (4 years on average), results from this study suggested a possible increased risk 
of leukaemia, lymphoma and brain tumours with increasing dose from CT. This effect disap-
peared when adjusted for the presence of predisposing factors, suggesting the results were 
confounded by predisposing factors.
A more in-depth analysis showed that for brain tumours and lymphoma, the risk esti-
mates among subjects with no predisposing factors were similar to those based on the entire 
cohort. For leukaemia the risk estimate among subjects without predisposing factors was 
higher than that in the entire cohort. These findings suggest that predisposing factors do not 
explain the observed association between CT dose and tumour risk in the cohort but may, 
rather, be modifiers of the association between radiation dose and risk of disease (differen-
tially affecting the observed effect of the exposure to doses from CT scan depending on the 
disease status) [47].
Results of analyses of data from the Dutch part of EPI-CT [48] also suggest that most 
cancer susceptibility syndromes are unlikely to confound the association between radiation 
dose and risk of disease. If other sub-studies in EPI-CT yield similar results, this will greatly 
facilitate the interpretation of results of CT studies in general and of the international EPI-CT 
study in particular.
Recently, however, Krille et al published results on the Germany component of the 
EPI-CT study [26]. The standardised incidence ratio (SIR) for lymphomas and solid cancers 
(11 and 9 cases respectively) decreased substantially when persons with medical conditions 
possibly associated with an increased risk of cancer were excluded. In contrast, the SIR for 
leukaemia changed only marginally. Based on small numbers, the authors concluded that 
still potential for reverse causation and confounding by indication could not be discarded 
when interpreting the excess of observed cancer cases compared with the expected number 
of cases [26].
Results of other sub-studies in EPI-CT are awaited. If results are similar to those of the 
French and Dutch study, this will greatly facilitate the interpretation of results of CT studies 
in general and of the international EPI-CT study in particular. If, however, they suggest that 
confounding by indication is a potential confounder, credible scenarios will be identified and 
simulation studies conducted to assess the influence of confounding by indication on risk 
estimates and to correct, if possible, for this potential bias in countries where no data are 
available.
2.2.3. Reverse causation
Epidemiological studies involving diagnostic ionising radiation exposure may suffer from 
confounding by indication, because the allocation of diagnostic procedures in observational 
studies is not randomised and may be related to the health outcome of interest for the study. 
Therefore, the difference in the underlying risk profile between the exposed and unexposed 
groups can bias the study results.
Within studies of CT patients, such as EPI-CT, scans possibly related to the cancer diag-
nosis or to symptoms caused by an underlying non-diagnosed cancer should be excluded in 
the estimation of cancer risk from CT radiation dose. However, information on the reason 
for the scan is often missing from radiology records. In countries where this is possibles 
work is being conducted with hospitals and registries to ensure that information is collected 
to help identify and exclude from analyses those patients whose scan may be linked to their 
cancer. The impact of this bias is also being assessed in several countries through sub-studies, 
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providing results that can be used through simulation or sensitivity analyses to evaluate the 
potential impact of this bias and adjust for it.
The French study [25] also studied the possibility of reverse causation, first, by applying 
various periods of exclusion (from 1 to 4 years), and then, by removing the CT scans per-
formed after the onset of first symptoms of cancer (for CNS tumours). The authors suggested 
that reverse causation potentially biased the risk estimates of CNS tumours, though the very 
short follow-up (average 4 years) prevents a definitive conclusion.
The German study [26] manually reviewed the available radiology reports and identified 
patients who had a CT scan due to signs of cancer at the time of the first CT and excluded them 
from analysis. Radiology reports were available for 37 cancer cases and 7 of them contained 
information on potential cancer signs at the time of their first CT scan. Although very rarely, 
delays of more than 2 years between the first signs possibly suggestive of cancer and the final 
cancer diagnosis were observed for seven cases and delays of more than 5 years for two cases. 
The potential residual reverse causation could lead to an overestimation of risks, and therefore 
results need to be carefully interpreted.
Analysis of medical records is also underway in several EPI-CT partner countries and 
will provide further information on this important topic. At the European level, moreover, 
analyses will exclude any scans occurring less than 2 years before diagnosis for leukae-
mia and 5 years for solid tumours, in order to minimise the potential for confounding by 
indication.
Should any of the sub-studies underway still suggest a residual effect of confounding by 
indication, the magnitude of such an effect will be estimated and simulation studies performed 
in order to assess the potential impact on the risk estimates from the study.
3. Discussion and impact
There is no doubt that the use of CT imaging is beneficial for millions of patients, but the 
potential adverse health effects related to the ionising radiation doses are a cause for concern 
in the radiological protection, medical and public health communities, and these effects are 
yet to be quantified with enough precision and certainty. Large studies of health effects of low 
doses of ionising radiation pose a number of important methodological challenges, particu-
larly in the medical setting where predisposing factors and confounding by indication may 
affect the adequacy and interpretability of the results. EPI-CT has been designed from the start 
to identify and characterise the potential magnitude of factors that may affect the bias of risk 
estimates so that they can be taken into account in the risk analyses.
Research addressing the diverse health effects of CTs, both for cancer and non-cancer 
diseases, is scarce and the available evidence is based either on risk projections [11, 12] or on 
studies too small for detailed evaluation of specific cancer subtypes [23, 24], despite including 
more than 100 000 subjects. EPI-CT is the first large-scale international collaborative study to 
contribute not only to estimating effects of low level radiation in children following CTs, but 
to consolidate a European paediatric cohort for very long-term follow-up. EPI-CT has been 
designed to improve on earlier studies by deriving individual organ-dose estimates for each 
cohort member, to evaluate related uncertainties, to analyse possible biases which may affect 
the results of the study, and thus provide the most comprehensive and precise direct estimates 
of cancer risk from CT scans received at young ages. It will therefore provide important infor-
mation to assess the adequacy of current radiation risk estimates (which are currently derived 
from studies of children with moderate to high doses received at high dose-rates from atomic 
bombings or radiotherapy) in relation to the generally lower doses received by CT patients. 
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This study should therefore have important implications for radiation protection and for opti-
mising paediatric CT examination protocols.
Although the approach chosen for the study is likely to miss some radiological exposures 
of study subjects, it is clear that extremely low-dose procedures such as conventional radiog-
raphy will have little impact on risk estimates and sub-studies to date within EPI-CT suggest 
Table 3. Country-specific differences in Ethical guidelines in observational follow-up 
cohorts, based on the EPI-CT experience.
Country
Requirements prior to start data collection from hospitals or medical trusts
National authority approval for 
collecting patient data
Ethical or other 
approval required 
in each individual 
hospital
Patients 
written 
consent Others
Belgium Yes—National Privacy Protection 
Commission (Commissie voor de 
bescherming van de persoonlijke 
levenssfeer–Commission de 
protection de la vie privée)
Yes No
Denmark Yes— National board of Health 
(Sundhedsstyrelsen)
No
France Yes—National Privacy protection 
Commission (Commission nationale 
Informatique et Liberté (CNIL))
No No Passive 
information 
(poster in 
radiology 
ward) of 
subjects is 
required
Germany No—National ethical approval 
gained from the Ethics Committee at 
the State Chamber of Physicians in 
the specific areas of the study
Data protection 
statement is 
required
No
Netherlands No No Noa
Norway Yes—Regional Committees for 
Medical and Health Research Ethics/
South-East (Regionale komiteer 
for medisinsk og helsefaglig 
forskningsetikk/Sør-Øst)
Varying No
Spain No Yes Depends on 
the hospital
Sweden Yes—Regional Ethical Review 
Board in Stockholm (Regionala 
Etkprövningsnämnden i Stockholm)
No No
UK Yes—Confidentiality Advisory 
Group (CAG) for England and 
Wales. For Scotland and Northern 
Ireland separate agreements were 
sought. One ethical approval covers 
the whole country
Yes No
a Submission to local IRBs is required which generally determine that only a feasibility check by the head of the 
hospital is required.
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that there is little potential for confounding due to other, generally unrelated, high dose medi-
cal procedures.
Other factors that will influence the accuracy and precision of dose estimates include: miss-
ing or incomplete information on the performed scan; uncertainties on machine settings for 
each examination; whether information was available from PACS or only from RIS; lack of 
precise information on patient characteristics and on exposed organs. The impact of these fac-
tors is being investigated within the dosimetry study and will be taken into account in the risk 
estimation [30].
Of concern also is that paediatric CT patients may not be representative of the general 
paediatric population. Preliminary data from the Netherlands (unpublished), Germany [28] 
and France [49] suggest that a sizeable proportion of CT patients (e.g. 15% in Germany), 
were examined because of a suspected cancer. Information is also being collected on 
whether subjects with conditions predisposing them to cancer (including Down syndrome 
and familial syndromes) may be overrepresented among patients undergoing CTs. Sub-
studies to date suggest that these are unlikely to confound the risk estimates though effect 
modification may be present. Should further sub-studies suggest an effect, it will be char-
acterised and simulation studies conducted to investigate its potential impact on the risk 
estimates from the study.
EPI-CT will assess the importance of SES as a potential confounder, allowing adjust-
ment of risk estimates where possible and corrections in countries where SES data might 
not be available for a large proportion of the cohort. Results of the association between SES 
and CT frequency available to date in our sub-studies suggest that this relation may differ 
between countries with different public healthcare systems [44]. Also, although SES has 
been related to risk of some cancers, the leukaemia and brain cancer literature is not con-
clusive regarding such associations [50] and analyses will be conducted to assess whether 
in fact SES confound the association between radiation dose from CT scans and risk of 
cancers.
Data on other potential confounding factors for specific outcomes are difficult to col-
lect systematically in such a large cohort due to heterogeneity both in information sources 
and confounding factor data availability. While potential risk factors for brain tumours and 
leukaemia—other than those mentioned above—are unlikely to be related to CT doses, 
nested case-control studies are planned to address this formally. In a second phase, Spain, 
the Netherlands and the UK are planning nested case-control studies of specific outcomes in 
order to obtain detailed information of both cases and controls that cannot be addressed in 
the full cohort.
Denmark, Norway, Sweden and the UK will provide data to assess the impact of potential 
loss to follow-up due to emigration.
4. Conclusion
Epidemiological studies of diagnostic radiation exposures aim to impact on clinical practice 
and public health and their results may have major implications for patient protection. It 
is very much hoped that the results of the EPI-CT study, in which majors efforts are being 
made to evaluate and adjust for factors which may invalidate the results, as well as in the 
 optimisation of paediatric imaging protocols, may help limit the radiation dose delivered to 
children and therefore reduce any potential risk arising from CT. At the same time results of 
EPI-CT may be an important component to empower physicians and parents for informed 
decision making.
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